Cardinal Health (CAH) FY2014 results: revenue $91.1 billion, down 9.9% on the year
Cardinal Health Inc. (CAH) reported revenue of $91.1 billion for fiscal 2014, the year ended 30 June 2014, down 9.9% on the year before. Net income was $1.2 billion, up 249.1%, and diluted earnings per share $3.38. The figures are the company's own, from the 10-K it filed with the SEC on 13 August 2014.
Revenue
$91.1 billion
-9.9% on the year
FY2008FY2014
Operating margin
2.1%
1.0% a year earlier
FY2008FY2014
Net income
$1.2 billion
+249.1% on the year
FY2008FY2014
Diluted EPS
$3.38
+248.5% on the year
FY2008FY2014
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Revenue
91,084
101,093
107,552
-9.9%
Cost of revenue
85,923
96,172
103,011
-10.7%
Gross profit
5,161
4,921
4,541
+4.9%
Gross margin
5.7%
4.9%
4.2%
Selling, general and administrative
3,028
2,875
2,677
+5.3%
Operating income
1,885
996
1,792
+89.3%
Operating margin
2.1%
1.0%
1.7%
Interest expense
133
123
95.0
+8.1%
Pre-tax income
1,798
888
1,698
+102.5%
Income tax
635
553
628
+14.8%
Effective tax rate
35.3%
62.3%
37.0%
Net income
1,166
334
1,069
+249.1%
Net margin
1.3%
0.3%
1.0%
Diluted EPS
$3.38
$0.97
$3.06
+248.5%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Operating cash flow
2,524
1,727
1,176
+46.1%
Capital expenditure
249
195
260
+27.7%
Free cash flow
2,275
1,532
916
+48.5%
Free cash flow margin
2.5%
1.5%
0.9%
Cash from investing
-850
-2,375
-377
Cash from financing
-710
275
-454
Depreciation and amortisation
459
397
325
+15.6%
Share-based compensation
96.0
93.0
85.0
+3.2%
Buybacks
673
450
450
+49.6%
Dividends paid
415
353
300
+17.6%
Dividend per share
$1.21
$1.02
$0.86
+18.0%
Diluted shares, weighted
345m
344m
349m
+0.3%
Balance sheet
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Shareholders' equity
6,401
5,975
6,244
+7.1%
Debt
3,972
3,854
2,894
+3.1%
Other liabilities
15,660
15,990
15,122
-2.1%
Total liabilities and equity
26,033
25,819
24,260
+0.8%
Fixed assets
1,459
1,489
1,551
-2.0%
Goodwill
4,878
4,601
3,978
+6.0%
Intangible assets
992
973
414
+2.0%
Investments
100
n/a
n/a
Cash and equivalents
2,865
1,901
2,274
+50.7%
Receivables
5,380
6,304
6,355
-14.7%
Inventory
8,266
8,373
7,864
-1.3%
Other assets
2,093
2,178
1,824
-3.9%
Total assets
26,033
25,819
24,260
+0.8%
10-K for the year ended 30 June 2014, filed 13 August 2014: the filing.